Frankfurt - Delayed Quote EUR

Demant A/S (WDH1.F)

31.38
+0.16
+(0.51%)
As of 8:02:52 AM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
22,419,000
22,419,000
21,601,000
19,705,000
17,905,000
Cost of Revenue
5,329,000
5,329,000
5,281,000
5,036,000
4,447,000
Gross Profit
17,090,000
17,090,000
16,320,000
14,669,000
13,458,000
Operating Expense
12,785,000
12,785,000
11,882,000
11,584,000
9,915,000
Operating Income
4,305,000
4,305,000
4,438,000
3,085,000
3,543,000
Net Non Operating Interest Income Expense
-767,000
-767,000
-612,000
-267,000
-204,000
Pretax Income
3,716,000
3,716,000
3,745,000
2,927,000
3,461,000
Tax Provision
824,000
824,000
922,000
651,000
750,000
Net Income Common Stockholders
2,387,000
2,387,000
1,795,000
2,082,000
2,513,000
Diluted NI Available to Com Stockholders
2,387,000
2,387,000
1,795,000
2,082,000
2,513,000
Basic EPS
10.99
--
8.04
9.21
10.70
Diluted EPS
10.99
--
8.04
9.21
10.70
Basic Average Shares
217,220
--
223,130
226,010
234,820
Diluted Average Shares
217,220
--
223,130
226,010
234,820
Total Operating Income as Reported
4,404,000
4,404,000
4,506,000
3,207,000
3,663,000
Total Expenses
18,114,000
18,114,000
17,163,000
16,620,000
14,362,000
Net Income from Continuing & Discontinued Operation
2,387,000
2,387,000
1,795,000
2,082,000
2,513,000
Normalized Income
2,794,528
2,794,528
2,820,000
2,274,000
2,696,000
Interest Income
101,000
101,000
84,000
56,000
38,000
Interest Expense
652,000
652,000
531,000
191,000
109,000
Net Interest Income
-767,000
-767,000
-612,000
-267,000
-204,000
EBIT
4,368,000
4,368,000
4,276,000
3,118,000
3,570,000
EBITDA
5,803,000
5,803,000
5,569,000
4,294,000
4,635,000
Reconciled Cost of Revenue
5,329,000
5,329,000
5,281,000
5,036,000
4,447,000
Reconciled Depreciation
1,435,000
1,435,000
1,293,000
1,176,000
1,065,000
Net Income from Continuing Operation Net Minority Interest
2,891,000
2,891,000
2,820,000
2,274,000
2,696,000
Total Unusual Items Excluding Goodwill
124,000
124,000
--
--
--
Total Unusual Items
124,000
124,000
--
--
--
Normalized EBITDA
5,679,000
5,679,000
5,569,000
4,294,000
4,635,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
27,528
27,528
--
--
--
12/31/2021 - 6/27/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PHBA.F Sonova Holding AG
52.00
-0.95%
 
OC5.F Cochlear Limited
154.70
+1.39%
 
NPCE NeuroPace, Inc.
11.98
+3.10%
 
SOON.SW Sonova Holding AG
253.70
+1.52%
 
LIVN LivaNova PLC
37.66
+0.40%
 
CHEMM.CO ChemoMetec A/S
477.20
+0.59%
 
NVNO enVVeno Medical Corporation
2.9700
+7.22%
 
GN.CO GN Store Nord A/S
98.54
-0.98%
 
GMED Globus Medical, Inc.
72.33
-0.40%
 
PEN Penumbra, Inc.
296.91
-0.14%